Matthew Buten

Matthew Buten is the Chief Financial Officer at Biohaven Pharmaceuticals in New York, with a background spanning roles at firms like Foresite Capital and Needham & Company. He has expertise in mergers and acquisitions, strategic planning, and venture capital, contributing to his success in leading financial operations at Biohaven Pharmaceuticals. Buten's career highlights include serving as a Managing Director at Foresite Capital and a Partner at Needham & Company, showcasing his experience in advising and managing financial strategies for various organizations.